Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Javed Khan, Berkley E. Gryder et al.|Cell Reports Medicine|2023Cited by 26
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcomaMeijie Tian, Javed Khan, Jun S. Wei et al.|Nature Communications|2024Cited by 26